Andrew Bzowyckyj/LinkedIn
Aug 1, 2026, 05:49
Andrew Bzowyckyj: New Therapies Transforming Chronic Kidney Disease Care
Andrew Bzowyckyj, Senior Scientific Director, Learning Consultant at National Kidney Foundation, shared a post on LinkedIn:
“Managing chronic kidney disease (CKD) has become increasingly complex, due in part to a rapid and promising increase in the number of pharmacologic therapies now available to slow CKD progression and reduce its associated cardiovascular risk.”
Stay updated with Hemostasis Today.
-
Aug 9, 2026, 07:32Heghine Khachatryan: Less Frequent INR Monitoring – Does It Necessarily Mean Poorer Anticoagulation Control?
-
Aug 9, 2026, 07:23Archil Jaliashvili: How Next-Generation Oxygen Carriers Build Healthcare Resilience
-
Aug 9, 2026, 07:13Victorien Monguillon: The Hidden Burden of Non-Major Extracranial Bleeding in Oral Anticoagulant Therapy
-
Aug 9, 2026, 02:26Exploring the Future of Rare Bleeding Disorder Treatment at EHC 2026
-
Aug 9, 2026, 02:08Shivam Bansal: Targeting Chemotherapy-Induced Thrombocytopenia in Children with Romiplostim
-
Aug 9, 2026, 01:48Paolo Zamboni: Treating Post-Thrombotic Syndrome by Eliminating Venous Reflux
-
Aug 8, 2026, 20:37Tammuella Chrisentery-Singleton: What Comes Next for Hemophilia Care With Non-Factor Therapies?
-
Aug 8, 2026, 20:36Michelle Cha: The Evolving Role of Nurse Coordinators in Hemophilia Gene Therapy
-
Aug 8, 2026, 20:35Benjamin Schumacher: The Future of Holistic Haemophilia A Care